Integration of Retroviruses into a Predetermined Site

  • Kelvin Davies
  • Ganjam Kalpana
Conference paper
Part of the NATO ASI Series book series (volume 105)


Retroviruses are currently the preferred vehicle for transduction of mammalian cells to be used in gene therapy. However, safety concerns limit their use at present to ex vivo procedures. One of the ultimate challenges for gene therapy will be to develop a vehicle for gene delivery that can be used in vivo. The vector of choice is likely to remain a retrovirus; one of its major advantages being that it can link therapeutic sequences to the host chromosome with stable covalent bonds. However, this positive attribute of retroviral vectors is potentially one of its major drawbacks. The integration of the viral genome, catalyzed by the enzyme integrase (IN), shows no discernible sequence specificity. There is the danger that such unpredictable integration of retroviral sequences could activate proto oncogenes potentially leading to carcinogenisis, or conversely, could lead to gene inactivation. However, integration is not completely random. Several studies have indicated that in vivo, many mouse retroviruses tend to integrate into DNAseI hypersensitive or transcriptionally active sites suggesting that there may be a bias towards open chromatin structures1,2,3,4,5. An even more pronounced bias in target site selection has been observed for retrotransposable elements such as Ty1 and Ty3 of yeast. Emerging evidence suggests that target site selection may be governed by host factors that associate with retroviral/retrotransposable element integration machinery6. By understanding the mechanism of target site selection by retroviruses, one may be able to modulate the process in such a way that retroviral integration can be directed to predetermined safe sites on the chromosome.


Human Immunodeficiency Virus Type Host Chromosome Viral cDNA Retrotransposable Element Preintegration Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Vijaya S, Steffen DL, Robinson HL, 1986. Acceptor sites for retroviral integrations map near DNAse I-hypersensitive sites in chromatin. J. Virol. 60: 683–692.PubMedGoogle Scholar
  2. 2.
    Rohdewohld H, Weiher H, Reik W, Jaenisch R, Breindl M, 1987. Retrovirus integration and chromatin structure: Moloney murine leukemia proviral integration sites map near DNAse I-hypersensitive sites. J. Virol 61: 336–343.PubMedGoogle Scholar
  3. 3.
    Scherdin U, Rhodes K, Breidl M, 1990. Transcriptionally active genome regions are preferred targets for retrovirus integration. J. Virol. 64: 907–912.PubMedGoogle Scholar
  4. 4.
    Shih C-C, Stoye JP, Coffin JM, 1988. Highly preferred targets for retroviral integration. Cell 53: 531–537.PubMedCrossRefGoogle Scholar
  5. 5.
    Withers-Ward ES, Kitamura Y, Barnes JP, Coffin JM, 1994. Distribution of targets for avian retrovirus DNA integration in vivo. Genes and Development 8: 1473–1487.PubMedCrossRefGoogle Scholar
  6. 6.
    Kalpana GV, Marmon S, Wang W, Crabtree GR, Goff SP, 1994. Binding and stimulation of HIV-1 integrase by a human homolog of yeast transcription factor SNF5. Science 266: 2002–2006.PubMedCrossRefGoogle Scholar
  7. 7.
    Bowerman B, Brown PO, Bishop JM, Varmus HE, 1989. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 3: 469–478.PubMedCrossRefGoogle Scholar
  8. 8.
    Farnet CM, Bushman F.D., 1997. HIV-1 cDNA integration: Requirement of HMG I(Y) protein for function of preintegration complexes in vitro. Cell 88: 483–492.PubMedCrossRefGoogle Scholar
  9. 9.
    Katzman M, Katz RA, Skalka AM, Leis J, 1989. The avian retroviral integration protein cleaves the terminal sequences of linear viral DNA at the in vivo sites of integration. J. Virol 63: 5319–5327.PubMedGoogle Scholar
  10. 10.
    Craigie R, Fujiwara T, Bushman F, 1990. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 62: 829–837.PubMedCrossRefGoogle Scholar
  11. 11.
    Ji H, Moore DP, Blomberg MA, Braiterman LT, Voytas DF, Natsoulis G, Boeke JD, 1993. Hotspots for unselected Ty1 transposition events on yeast chromosome III are near tRNA genes and LTR sequences. Cell 73: 1007–1018.PubMedCrossRefGoogle Scholar
  12. 12.
    Chalker DL, Sandmeyer SB, 1992. Ty3 integrates within the region of RNA polymerase III transcription initiation. Genes Dev. 6: 117–128.PubMedCrossRefGoogle Scholar
  13. 13.
    Kitamura Y, Ha Lee YM, Coffin JM, 1992. Nonrandom integration of retroviral DNA in vitro: Effect of CpG methylation. Proc. Natl. Acad. Sci. 89: 5532–5536.PubMedCrossRefGoogle Scholar
  14. 14.
    Wolffe AP, 1994. Switched-on chromatin. Current Biology 4: 525–528.PubMedCrossRefGoogle Scholar
  15. 15.
    Pryciak PM, Varmus, H.E., 1992. Nucleosomes, DNA-binding proteins, and DNA sequence modulate retroviral integration target site selection. Cell 69: 769–780.PubMedCrossRefGoogle Scholar
  16. 16.
    Pryciak PM, Sil A, Varmus HA, 1992. Retroviral integration into minichromosomes in vitro. EMBO J. 11: 769–780.Google Scholar
  17. 17.
    Shibagaki Y., Chow, SA., 1997. Central Core Domain of Retroviral Integrase is Responsible for Target Site Selection. J. Biol. Chem. 272: 8361–8369.PubMedCrossRefGoogle Scholar
  18. 18.
    Laurent BC, Treitel MA, Carlson M, 1990. The SNF5 protein of Saccharomyces cerevisiae is a glutamine- and proline-rich transcriptional activator that affects expression of a broad spectrum of genes. Mol. Cell. Biol. 10: 5616–5625.PubMedGoogle Scholar
  19. 19.
    Muchardt C, Reyes, J.C., Bourachot, B., Leguoy, E. and Yaniv, M., 1996. The hbrm and BRG-1 proteins components of the SNF/SWÏ complex, are phosphorylated and excluded from the condensed chromosomes during mitosis. EMBO J 15: 3394–3402.PubMedGoogle Scholar
  20. 20.
    Wang W, Cote J, Zhou S, Muchardt C, Khavari P, Bigger SR, Xue Y, Kalpana GV, Goff SP, Yaniv M, Tjian R, Workman J, Crabtree G, 1996. Identification of multiple forms of SWÏ/SNF complexes in mammalian cells: implication for its diverse function in development and tissue-specific gene expression. Submitted.Google Scholar
  21. 21.
    Wang W, Xue, Y., Zhou, S. Kuo, A., Cairns, B.R. and Crabtree, G.R., 1996. Diversity and specialization of mammalian SWI/SNF complexes. Genes and development 10: 2117–2130.PubMedCrossRefGoogle Scholar
  22. 22.
    Imbalzano AN, Know H, Green MR, Kingston RE, 1994. Facilitated binding of TATA-binding protein to nucleosomal DNA. Nature 370: 481–485.PubMedCrossRefGoogle Scholar
  23. 23.
    Kwon H, Imbalzano A, Khavari PA, Kingston RE, Green MR, 1994. Nucleosome disruption and enhancement of activator binding by a human SWI/SNF complex. Nature 370: 477–481.PubMedCrossRefGoogle Scholar
  24. 24.
    Goulaouic H, Chow SA, 1996. Directed Integration of Viral DNA mediated by Fusion Proteins Consisting of Human Immunodeficiency Virus Type 1 Integrase and Escherichia coli LexA Protein. J. Virology 70: 37–46.PubMedGoogle Scholar
  25. 25.
    Katz RA, Merkel G, Skalka AM, 1996. Targeting of Retroviral Integrase by Fusion to a Heterologous DNA Binding domain: In vitro Activities and Incorporation of a Fusion Protein into Viral Particles. Virology 217: 178–190.PubMedCrossRefGoogle Scholar
  26. 26.
    Bushman FD, 1994. Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Pro. Natl. Acad. Sci. U.S.A. 91: 9233–9237.CrossRefGoogle Scholar
  27. 27.
    Bushman FD, Miller MD, 1997. Tethering Human Immunodeficiency Virus Type 1 Preintegration Complexes to Target DNA Promotes Integration at Nearby Sites. J. Virology 71: 458–464.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Kelvin Davies
    • 1
  • Ganjam Kalpana
    • 1
  1. 1.Dept. of Molecular Genetics, Ullman 823BronxUSA

Personalised recommendations